Although these drugs inhibited BACE1 successfully, they did not improve cognitive functions in AD patient because BACE1 cleaves substrates for various functions, especially in neuron cell excitability regulation and axonal myelination [39]. This evidence concerns the gene BACE1 and Alzheimer disease.